Process validation and preclinical development of a new PET cerebral blood flow tracer [11C]MMP for initial clinical trials

Abstract Background 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) is commonly used for diagnosis of dementia because brain glucose metabolism reflects neuronal activity. However, as [18F]FDG is an analogue of glucose, accumulation of tracer in the brain is affected by plasma glucose levels. In contrast...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jun Toyohara (Auteur), Tetsuro Tago (Auteur), Muneyuki Sakata (Auteur)
Format: Livre
Publié: SpringerOpen, 2024-07-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Connect to this object online.

3rd Floor Main Library

Informations d'exemplaires de 3rd Floor Main Library
Cote: A1234.567
Exemplaire 1 Disponible